Daily Actions
Daily Actions
MARKET CONTEXT: SPY $764.29 (RSI 50.3, +16.22% 1Y, +7% vs 200-day — cooled off but an intact secular trend) | QQQ $714.88 (RSI 50.8, +22.39% 1Y, +8.3% vs 200-day) | VIXY $17.30 (RSI 39.6, first uptick out of collapse this stretch, still -32.5% vs 200-day and -47.14% 1Y — no real hedging bid yet) | GLD $398.77 (RSI 47.5, -4.1% vs 200-day, was -2.1% last cycle — hit, not lifted, the same session oil and rates spiked)
Price truth: every price/RSI/trend figure below is read from the 2026-09-11-dated research/market-engine/data/summaries/*.json files (spot-checked directly against source for retail.json, biotech-scan.json, drone-defense.json, defense-contractors.json, bargain-bin.json, tech-insider-buys.json, cybersec.json, mag7.json, market-pulse.json and 20+ others this session — no ticker below failed that check), sourced through all 31 of today's scans (skipping monster-discover, invalidated) and all 11 candidate roundups. Tracked company profiles have not refreshed for 2026-09-11 except ORCL, whose fresh September 11 profile is folded in below for signal only, with its own price/RSI figures re-confirmed against today's summaries. Book-blind this cycle by explicit instruction: research/trading/ and holdings were not read, so Exit Alerts is empty below — that is a scope decision, not a data gap. Regime transitions are the code-diffed regimes:feed --json output for 2026-09-11 vs 2026-09-10 (54 items), read directly, not eyeballed. The most recent prior digest is 2026-09-04 (a 7-day gap); carry-forward below is against that file.
Summary
The rates-not-fear story that opened last cycle sharpened into an outright credit event this week, and it is now the single biggest thing happening on the desk's board. The bond complex crossed from "oversold" into capitulation-adjacent territory — IEF (RSI 26.4), HYG (28.3), BND (28.7) and LQD (29.8) all sit at or below 30, every one death-crossed and negative on both the trailing year and vs its 200-day (market-pulse) — while oil kept extending (USO +112.19% 1Y, RSI 71.9, 41.9% above its 200-day) and gold and silver both took a direct hit rather than a haven bid (GLD's gap below its 200-day widened to -4.1% from -2.1%, SLV's to -11.4% from -8.4%) during the exact dated session this desk's own September 10 brief documents: crude past $100 a barrel and the ten-year Treasury yield above 4.9%, its highest since 2023, with 844 of 1,115 names on the broad tape closing lower (CNBC/Bloomberg, September 10, cited across today's defense-contractors, geopolitical-risk and macro-commodities scans). Defense is the cleanest confirmation this is a rates story and not a war story: L3Harris (LHX) fell into a full collapse regime (RSI 24.9, now negative on both the trailing year and vs its 200-day) and RTX is the only prime left standing above its own 200-day, even as oil producers and refiners run hot on the same live Middle East backdrop.
Underneath that macro story, breadth cooled almost everywhere at once — 53 of 56 names on the market-pulse board eased on RSI, and the oversold band more than doubled from 8 to 18 names — but the broad equity benchmarks and most sector leadership stayed above their 200-day with double-digit trailing-year gains, which the desk's own long-horizon rule calls a deep pullback, not a breakdown. Consumer and retail took the sharpest individual hits: TJX deepened into capitulation for a third straight scan (RSI 17.8, trailing year now negative for the first time) on nothing newer than a three-week-old downgrade; Starbucks and Domino's both cratered with no cause established in either's news receipt (both stale/failed); Home Depot, Lowe's, Nike and now Yum! Brands all sit below their 200-day with negative trailing-year returns. Healthcare and biotech cracked the same way — the whole biotech-scan cohort cooled below RSI 62 for the first time this stretch, and Amgen's 31-point RSI collapse (still +33.5% 1Y, still above its 200-day) has no sourced driver across three separate checks this session.
A handful of confirmed, dated catalysts sit inside all that noise. Constellation Energy (CEG) crossed back below its 200-day on a fresh, sourced $3.09 billion equity raise (news fetched today) that reverses the recovery the desk has tracked for two straight cycles. AeroVironment (AVAV) delivered a real, volume-confirmed Q1 FY27 beat-and-raise that still landed inside a chart 30% below its 200-day. Ciena (CIEN) is now confirmed via a fresh news pull on its fiscal Q3 beat-and-raise, recovering but still 8.1% below its own 200-day. Cloudflare (NET, a focus-list name) posted the board's best week on this desk (+9.9%) with a sourced driver — new OpenAI and SpaceX partnership news fetched today — while remaining 36.5% above its 200-day, not oversold. And Oracle's fresh September 11 profile (folded in for signal, not entry-zone eligible at RSI 51) turns a $664 billion demand backlog into a financing question: the company drained its entire $20 billion equity program in one quarter and ran negative free cash flow for a fifth straight quarter — the $167.64 200-day is the level the profile itself names as the test.
Entry Zones (IN ZONE NOW)
Every name below is a common-stock or index-ETF listing with normal trade access. Foreign primaries and OTC/ADR mirrors that showed genuinely oversold reads this cycle — $BYDDY (RSI 31.2, Hong Kong-listed BYD ADR), $BESIY (38.6), $KRKNF (28.6), $DRSHF (39.1) and $LPK.DE (39.4) — are excluded by design; research-only extends to $SFTBY (RSI 70.1, an unsponsored SoftBank OTC ADR, overbought not oversold but flagged for the same reason). $ATAI did not trade Friday (halted; last print carries a 09-10 stamp) and $PHGE returned no data this session — neither gets a row. Leveraged/inverse products (SOXL, TQQQ, TNA, SOXS, TECL and the rest) are never entry candidates per standing policy and are omitted entirely.
EXTREME OVERSOLD (RSI < 20) - Capitulation Territory
| Stock | Current | Zone | RSI | 30D Chg | Source | Action | Notes |
|---|---|---|---|---|---|---|---|
| TJX | $126.02 | No support shelf identified | 17.8↓ | -17.42% | retail-scan, retail candidate | ⚠️ Avoid | Third straight scan deepening into capitulation; trailing year has now turned negative (-10.52%) for the first time; only a stale (3-week) Jefferies downgrade on file |
OVERSOLD (RSI 20-30) - Strong Entry Zone
| Stock | Current | Zone | RSI | 30D Chg | Source | Action | Notes |
|---|---|---|---|---|---|---|---|
| RARE | $14.30 | No support shelf identified | 20.2↓ | -46.76% | biotech-scan | 🔍 Watch | Deepening for a second straight scan, now -54.2% 1Y; news receipt stale (fetched 09-04), stock-events checked — no cause found either time |
| HRL | $20.57 | No support shelf identified | 23.2↓ | -15.7% (7D -4.5%) | defensive-scan | 🔍 Watch | Cut's new deepest print for a second straight scan, -19.1% 1Y, no confirmed floor |
| PL | $16.45 | none | 23.5↓ | -32.86% | drone-defense | ❌ Don't Buy | Weakest reading in its book despite a confirmed Q2 beat; desk's own thesis rating is broken; soft Q3 guidance and a 28%+ price-target cut are the confirmed drag |
| RCL | $260.14 | Below 200-day (-9.7%, deepening) | 24.4↓ | -15.54% | travel-leisure | ⚠️ Avoid | Broken on every window, breach still deepening, -25.72% 1Y |
| LHX | $245.54 | No support shelf on file | 24.9↓ | -15.55% | defense-contractors, geopolitical-risk (2x) | ⚠️ Avoid | Fell into a full collapse regime this scan — now negative on both 1Y (-12.5%) and vs 200-day (-21.7%); the book's clearest broken-trend name |
| NIO | $3.69 | none | 27.3↓ | -18.72% | ev-clean-energy | 🔍 Watch | Stabilizing off last cycle's capitulation print (RSI 24.5) but still 28.7% below its 200-day, -39.21% 1Y |
| SYK | $275.56 | No support shelf identified | 27.8↓ | -20.6% (7D -9.1%) | healthcare-scan | ⚠️ Avoid / breakdown watch | Deepening for a second straight scan, -29.1% 1Y; fresh news pull (09-11) returned only routine coverage, no cause found |
| NCLH | $14.82 | 25.1% below 200-day (deepening) | 28.3↓ | -21.67% | travel-leisure | ⚠️ Avoid | Cohort's clear worst on every measure and still worsening, -44.99% 1Y, alpha -61.21 |
| ITA | $219.01 | Below 200-day | 28.5↓ | -12.96% | defense-contractors, drone-defense, geopolitical-risk | 🔍 Watch | Deepest oversold print in the defense book, but still +9.47% 1Y — deep pullback in an intact trend, not yet a break |
| DD | $126.99 | none | 29.2↓ | -12.04% | chemicals, bargain-bin | 📈 Accumulate | Sector's best one-year performer (+29.77%) and best alpha (+13.55) by a wide margin — oversold RSI inside an intact trend |
| HON | $202.36 | Below 20-day (-5.9%) | 29.3↓ | -14.01% | bargain-bin | 🔍 Watch | Fresh strict bargain-bin hit (RSI<30 and below its 20-day), first in the tracked window after two zero-hit cycles; news receipt stale (fetched 06-21) — cause unknown |
| BKNG | $173.92 | Below 200-day (-6.3%, newly crossed) | 30.0 | -18.06% | travel-leisure, bargain-bin | ⚠️ Avoid | Two-scan horizon mismatch (technically above its 200-day, quietly losing to the market) resolved into a confirmed break this week — sharpest weekly decline in its sector (-10.02%) |
| CCL | $22.75 | 17.9% below 200-day | 30.0 | -17.78% | travel-leisure | ⚠️ Avoid | Still strong-down with a confirmed death cross, -29.94% 1Y |
APPROACHING OVERSOLD (RSI 30-40) - Watch Closely
| Stock | Current | Zone | RSI | 30D Chg | Source | Action | Notes |
|---|---|---|---|---|---|---|---|
| CRS | $443.19 | none | 30.1 | -16.16% | supply-chain-traces | 📈 Accumulate | Lowest RSI in its book but still +82.25% 1Y with +66.03 alpha — deep pullback, not a breakdown, on the horizon evidence |
| PPA | $161.81 | none | 30.8 | -12.28% | defense-contractors | 🔍 Watch | Basing regime, mixed 1Y/vs-200-day, not yet confirmed either way |
| LCID | $4.22 | 49.2% below 200-day (deepening) | 30.8 | -35.47% | ev-clean-energy | ❌ Don't Buy | Board's weakest EV structure by a wide margin, still deteriorating — 83.27% below its 52-week high, -78.79% 1Y |
| MCD | $252.53 | 14.4% below 200-day | 31.2 | -8.40% | retail, defensive-scan, bargain-bin | ⚠️ Avoid — oversold but unconfirmed | Below its 200-day with a negative trailing year (-18.12%); no confirmed floor |
| AMGN | $377.35 | Watch $425.38 (its 20-day) | 31.5 | -9.3% (7D -13.7%) | biotech-scan, healthcare-scan, tech-insider-buys, biotech candidate (4x) | 🔍 Watch | 31-point RSI collapse with no established cause across three separate checks this session; still +33.5% 1Y, +5.0% above its 200-day — a sharp pullback inside an intact trend, not yet a breakdown |
| GD | $355.90 | Support $351.44 | 31.9 | -9.72% | defense-contractors, geopolitical-risk (2x) | 🔍 Watch — trend testing average | Essentially flat vs its 200-day (+0.3%), softest RSI among the still-positive-1Y primes |
| SBUX | $98.74 | <$97.64 (prior support level) | 31.8↓ | -8.99% (7D -5.48%) | consumer, retail, defensive, cultural-thesis (4x) | 🔍 Watch | Sharpest RSI drop in three of today's scans with no confirmed cause (stale news, fetched July 15); still 0.8% above its 200-day, +19.9% 1Y — holds, barely |
| IMVT | $37.36 | Watch $41.58 (its 20-day) | 31.8↓ | -12.3% | biotech-scan | 🔍 Watch | Crashed into oversold this scan but remains +122.4% 1Y, 21% above its 200-day |
| RTX | $197.68 | Support $195.15 | 32.1 | -11.26% | defense-contractors, geopolitical-risk (2x) | 🔍 Watch | The only prime still above its own 200-day (+2.1%, narrowing), best trailing-year in the book (+25.39%) |
| HD | $308.74 | No support shelf identified | 32.3 | -10.10% | retail, defensive-scan | ⚠️ Avoid | Genuine breakdown, deepened again this scan, -27.1% 1Y |
| CRDO | $162.95 | Watch for stabilization before entry | 33.2 | -39.23% | tech-insider-buys | 🔍 Watch | Post-earnings margin-scare damage kept compounding (30D worsened from -24.07%); confirmed underlying beat still on file, but no fresh cause explains this week's further slide |
| LOW | $196.82 | 16.5% below 200-day | 33.8 | -8.87% | retail, defensive, bargain-bin | ⚠️ Avoid | -27.75% 1Y, regime flipped downtrend→collapse per the code-diffed transitions feed (thesis still rated intact by the desk) |
| LULU | $98.97 | 34.7% below 200-day | 33.9↓ | -18.12% | consumer, retail, cultural-thesis, bargain-bin (4x) | ⚠️ Avoid | RSI ticked up off last cycle's crash but every long-horizon field stays deeply negative (-40.3% 1Y, alpha -56.52) — not a repair |
| NKE | $36.80 | 27.7% below 200-day | 34.2 | -9.16% | consumer, retail, bargain-bin, cultural-thesis (4x) | ❌ Don't Buy | Cohort's clearest structural breakdown, essentially unchanged, -50.49% 1Y, alpha -66.71 |
| YUM | $140.87 | 9% below 200-day (newly) | 34.2 | -6.30% | retail-scan | ⚠️ Avoid | This cycle's clearest new deterioration — 1Y flipped negative (-5.55%, was +4.9%) |
| PPG | $105.50 | none | 34.4 | -7.94% | chemicals | ⚠️ Avoid | Sector's sharpest weekly decline (-6.25%); 1Y flipped negative, alpha worsened to -21.88 |
| COGT | $33.41 | Watch $35.73 (its 200-day) | 34.6 | -14.3% | biotech-scan | 🔍 Watch | Still testing its 200-day from below after a huge multi-year run (+160.8% 1Y) |
| DPZ | $311.60 | 14.2% below 200-day | 34.8 | -11.91% | consumer, retail, cultural-thesis (3x) | 🔍 Research | Board's sharpest single-name move in two scans (-8.64% week); failed news fetch on record — no cause established; compounds an already-negative horizon read (-31.76% 1Y) |
| ALB | $117.52 | 25.0% below 200-day | 34.9 | -8.43% | ev-clean-energy | 🔍 Watch | Sold off hard with no catalyst on file, but still +56.59% 1Y — deep pullback, not a break |
| SQM | $69.88 | 8.5% below 200-day | 36.0 | -1.92% (7D -8.57%) | ev-clean-energy | 🔍 Watch | Lithium complex's softest week of this stretch, no catalyst on file, but still +64.0% 1Y — deep pullback, not a break |
| LLY | $1,115.70 | none | 35.4 | -8.6% | healthcare-scan, biotech-scan, biotech candidate (3x) | 📈 Accumulate | Deep pullback inside an intact trend, +47.5% 1Y |
| TDY | $603.79 | none | 35.5 | -12.05% | supply-chain-traces, drone-defense (2x) | 🔍 Watch | Alpha1y has turned negative behind a still-positive headline 1-year return (+6.66%) — the earlier-stage version of a genuine breakdown |
| COST | $904.77 | 5.8% below 200-day (newly) | 35.5 | -4.72% | bargain-bin, defensive, retail candidate (3x) | ⚠️ Avoid | 1Y turned negative for a second straight scan and deepened (-6.18%, was -4.2%) |
| NEE | $82.31 | Below 200-day (-6.2%, newly) | 36.4 | -4.05% | ai-scan | 🔍 Watch | Fell newly into oversold but still +15.41% 1Y |
| SOUN | $6.26 | 19.2% below 200-day | 36.7 | -15.41% | ai-scan | ⚠️ Avoid | Fell into oversold, deeply broken, -57.06% 1Y |
| TSN | $52.98 | 12.4% below 200-day | 38.0 | -5.1% (7D +3.0%) | defensive-scan | 🔍 Watch | Still below its 200-day with a negative-to-flat year (-5.5%) |
| RUN | $8.56 | 40.2% below 200-day | 38.7 | -13.01% | ai-scan | ⚠️ Avoid | Fell into oversold, deeply broken, -46.53% 1Y |
| OKLO | $36.22 | 43.2% below 200-day | 38.7 | -19.74% (7D -12.24%) | ai-scan | ⚠️ Avoid | Continued deterioration with no fresh cause on file (news last meaningfully updated 08-25); -54.71% 1Y |
| PATH | $13.75 | none | 38.9 | -9.90% | ai-scan | ⚠️ Avoid | Third straight cycle falling, trend flipped weak-down for the first time; still +17.62% 1Y and +6.6% above its 200-day — a deep pullback, not yet a breakdown |
| SHOP | $128.79 | Below 200-day (-1.7%, newly) | 39.3 | -14.37% | retail-scan | 🔍 Watch | Board's worst week with no catalyst on file (news receipt returned only generic portal pages); trend now genuinely under test, not clearly intact — a focus-list name |
| CROX | $112.48 | none | 36.3 | -13.88% | consumer, retail, cultural-thesis (3x) | 📈 Accumulate | The one name across three of today's scans clean on every horizon without a caveat — above its 200-day, +38.95% 1Y, positive alpha |
(Volatility products and the whole bond complex — IEF 26.4, HYG 28.3, BND 28.7, LQD 29.8, TLT 35.2 — all sit in or near this RSI band on market-pulse.json but are excluded from the table above: every one is death-crossed and negative on both the trailing year and vs its 200-day, a genuine capitulation-adjacent credit read, not an entry — see Sector Rotation below. Dozens more names cluster near this band inside today's AI-power reversal (VST, EOSE, SEDG, FSLR, TAC, ENPH, SMR, RGTI, QBTS, BBAI) and the chemicals sector's broadening deterioration (SHW -3.2% vs 200-day, APD -1.05% 1Y, LIN -3.59% 1Y) — the table above is the cross-confirmed, highest-signal subset, not the full list.)
🔴 THE RATES STORY SHARPENED — the day's key cross-asset read
| Signal | What Happened | Structure Underneath | Status |
|---|---|---|---|
| Bond complex capitulation | IEF 26.4, HYG 28.3, BND 28.7, LQD 29.8, TLT 35.2 — all death-crossed, negative on 1Y and vs 200-day (market-pulse) |
Deepened from "oversold" straight into capitulation-adjacent territory in one scan, the sharpest single-corner move on the whole board | 🔴 Live, unresolved |
| Oil vs. gold/silver divergence | USO +112.19% 1Y, RSI 71.9, 41.9% above its 200-day, still extending, while GLD's gap below its 200-day widened to -4.1% (was -2.1%) and SLV's to -11.4% (was -8.4%) the same dated session (macro-commodities, geopolitical-risk) |
Neither safe-haven asset confirms a fear trade — reinforces rates/inflation over war-premium | 🔴 Live |
| Defense still failing to catch a war bid | LHX fell into full collapse (RSI 24.9); RTX is the only prime left above its own 200-day |
Whole prime-contractor book sold off during a live, dated Middle East exchange — the opposite of a naive war-premium read | 🔴 Unresolved |
| Broad breadth cooldown, benchmarks still intact | 53/56 market-pulse names cooled on RSI, oversold band doubled 8→18; SPY/QQQ/VTI all stayed above their 200-day with double-digit 1Y gains | A deep pullback across the broad market per the desk's own long-horizon rule, not (yet) a breakdown | 🟡 Watch for confirmation |
Price Alerts (Waiting for Entry)
| Stock | Alert | Entry Zone | Source | Set Date | Status |
|---|---|---|---|---|---|
| META | Pullback entry | $600-630 | ai-scan | 07-11 | 🟠 Price ran past the zone ($648.03, RSI 67.2) and crossed back above its 200-day (+4.0%) for the first time this stretch — 1Y improved to -13.70% (was -17.62%) but stays negative; healing, not repaired, no longer a dip-buy |
| CEG | Golden-cross flip | — | ai-scan, tech-insider-buys, energy candidate | 07-11 | 🔴 Reversed — crossed back below its 200-day this cycle (-3.6%, was +0.9%), regime tagged downtrend; a fresh, sourced $3.09B equity raise (news fetched 09-11) is the plausible dilution-driven driver; 1Y deepened to -10.46% |
| T | Golden-cross flip | — | defensive-scan, ai-scan | 07-11 | 🟡 Partial, unresolved — RSI 61.9, +3.6% above its 200-day, but 1Y still negative (-11.63%) and alpha still deeply negative |
| GLD / URA | Watch for a golden-cross flip | — | macro-commodities, etf-universe, geopolitical-risk, market-pulse | 07-25 | 🔴 Resolving the wrong way — GLD's gap below its 200-day widened again to -4.1% (was -2.1%); URA's widened to -10.3% (was -5.0%), 1Y compressed to +2.06% with alpha now negative (-14.16) |
| HUBS | Watch whether the divergence resolves | — | tech-insider-buys | 08-08 | 🔴 Persists — still -54.64% 1Y, the deepest structural laggard in its universe besides IONQ's short-window collapse |
| AVGO | Watch its 200-day test resolve | — | ai-scan, bargain-bin, nvda-ecosystem, tech-insider-buys, insider-scan | 08-22 | 🟡 Recovered out of oversold (RSI 42.2, was 38.1) but stays below its 200-day (-2.2%) despite a confirmed Sept 2 EPS beat — persistent laggard |
| SMCI | Watch whether the 1Y ever turns positive | — | tech-insider-buys | 08-28 | 🔴 Reopened — deficit widened back to -8.76% after nearly closing to -2.73% last cycle; no news receipt covers the reversal |
| TEAM | Watch whether the extension cools | — | tech-insider-buys, monster-scan | 08-28 | 🟡 Still extended — RSI 61, +63.5% above its 200-day |
| ISRG | Thesis flag vs. chart divergence | — | insider-scan, biotech-scan, healthcare-scan | 08-28 | 🔴 Persists, sixth straight scan — -19.0% 1Y, -19.7% vs its 200-day, thesisState: intact against a genuinely broken chart |
| ORCL | Watch the 200-day / financing test | $167.64 (its 200-day) reclaim on above-average volume, or $140.68 (its 50-day) loss | 2026-09-11 company profile | 09-11 | 🆕 New — RSI 51, -51.19% 1Y, drained its entire $20B at-the-market equity program in one quarter and ran a fifth straight negative-free-cash-flow quarter; the profile's own kill-test levels are the thing to watch |
Exit Alerts (Holdings)
Book-blind boundary, this cycle by explicit instruction: no ledger, account, or holdings data was read to produce this digest — research/trading/ and holdings were out of scope for this pass. Zero rows below is a scope decision, not a data gap; position management should be read from the standard holdings snapshot the next time this section is populated.
| Account | Position | Current | RSI | Your Gain | First Buy | Status |
|---|---|---|---|---|---|---|
| — | — | — | — | — | — | Not populated this cycle (book-blind by instruction) |
Sector Rotation Signals
| Signal | Trigger | What It Means | Status |
|---|---|---|---|
| Bond complex slid into capitulation-adjacent territory | IEF (26.4), HYG (28.3), BND (28.7), LQD (29.8) all fell from oversold toward capitulation; all five (with TLT) death-crossed and negative on 1Y/vs-200-day (market-pulse) |
Credit is the one place real deterioration is now unambiguous underneath a broad tape that still looks orderly | 🔴 Watch closely — possible credit-stress episode |
| Oil accelerating while gold/silver take a direct hit | USO +112.19% 1Y, RSI 71.9, pushing toward overbought; GLD/SLV both widened their gap below the 200-day the same dated rate-shock session (CNBC/Bloomberg, Sept 10) | Rates/inflation story sharpening, not a fear trade — the desk's read from last cycle confirmed with a specific dated receipt this time | 🔴 Live, unresolved |
| Defense still can't catch a war bid | LHX fell into full collapse (RSI 24.9); RTX is now the only prime above its own 200-day |
The sector most directly named by any Middle East conflict narrative keeps trading as a rates proxy, not a war-premium name | 🔴 Unresolved |
| Consumer/retail broad oversold rotation | TJX (17.8, 3rd-straight-scan capitulation), SBUX/DPZ (both fresh unexplained drops), HD/LOW/NKE/YUM (confirmed below-200-day breakdowns) — 15+ names across consumer-scan/retail-scan/bargain-bin/defensive-scan/cultural-thesis now sit RSI 30-40 | A genuinely broad consumer-sector rotation into oversold, not isolated single-name weakness | 🟡 Watch which names find a floor vs. keep deteriorating |
| Chemicals deterioration broadened beyond Dow | PPG posted the sector's sharpest weekly decline (-6.25%, 1Y flipped negative); Sherwin-Williams, Air Products and Linde all newly crossed or deepened below their 200-day this week | The single-name story two cycles ago (Dow's death cross) is now a sector-wide re-rate | 🔴 Watch for further widening |
| Cruise-line trio and Booking/Hilton confirmed broken | RCL/CCL/NCLH all deepened further below their 200-day; BKNG's two-scan horizon mismatch resolved into a confirmed break this week, Hilton crossed below for the first time | Two-tier travel-sector breakdown: cruise lines fully broken, hotels/booking now joining | 🔴 Confirmed, widening |
| AI-power/quantum relief rally reversed | CEG crossed back below its 200-day on a dilutive $3.09B raise; SMR, RUN, OKLO, SOUN all deteriorated further into or through oversold with no fresh cause on file | Last cycle's broad relief rally in this cohort has almost entirely round-tripped; only BE holds its gains cleanly (ai-scan) |
🔴 Confirmed reversal |
| WFE/test-metrology equipment layer keeps extending its bounce | 9 of 14 names gained RSI this cycle on top of last cycle's clean sweep; every single name in the book still carries a positive alpha1y — no exceptions | The semicap-equipment layer stays the cleanest "deep pullback in an intact trend" case on the whole board | 🟢 Confirming |
Regime Transitions
Source: regimes:feed --json (code-diffed, not eyeballed). Newest group dated 2026-09-11, prior bar 2026-09-10 — 54 items, no from: null/to: null rows to skip this cycle; 9 of the 54 are flagged inert (universe churn on already-decayed names, not fresh signal).
| Stock | From | To | Thesis | Tape Date |
|---|---|---|---|---|
| SHOP | pullback | downtrend | unrated | 2026-09-11 |
| NET | pullback | uptrend | intact | 2026-09-11 |
| GOOGL | pullback | basing | intact | 2026-09-11 |
| META | downtrend | pullback | unrated | 2026-09-11 |
| GD | uptrend | pullback | unrated | 2026-09-11 |
| LOW | downtrend | collapse | intact (inert) | 2026-09-11 |
| ZTS | downtrend | collapse | unrated (inert) | 2026-09-11 |
| ABCL | uptrend | pullback | intact-but-priced | 2026-09-11 |
| IREN | collapse | downtrend | unrated (inert) | 2026-09-11 |
SHOP's pullback→downtrend cross-confirms retail-scan's own read (board's worst week, newly below its 200-day, no catalyst on file) — SHOP is on the desk's focus watchlist. NET's pullback→uptrend and GOOGL's pullback→basing both cross-confirm this cycle's cleaner reads (NET's sourced OpenAI/SpaceX pop; GOOGL's thinning-but-still-leading 200-day cushion). META's downtrend→pullback matches ai-scan's flagged cross back above its 200-day. GD's uptrend→pullback matches the defense-contractors read directly. LOW and ZTS both flip to collapse but are flagged inert — already-decayed names, not a fresh break. The remaining 45 items are broad-tape churn: 12 uptrend→pullback, 8 downtrend→collapse, 6 pullback→downtrend, 6 uptrend→basing, and smaller counts elsewhere — a genuine board-wide cooling, matching this cycle's breadth story, thesisState: unrated throughout except the eight named above.
Insider Activity Summary
| Signal | Stocks | Implication |
|---|---|---|
| Buying table narrowed for the first time in this tracked window | ASAN (+$8.7M, unchanged), INTC (+$2.4M, unchanged), TSM (+$1.5M, down from +$1.8M) — only 3 names, down from 5 last cycle; TSLA and CRSP both dropped off the buying list entirely | A real narrowing of insider conviction in this universe, though the desk cannot confirm from this pull whether TSLA/CRSP's flow reversed or fell below the reporting floor |
| Golden signal (RSI<30 + buying): zero for a sixth straight cycle | None — closest approach is PINS at RSI 30.8, itself structurally broken (-45% 1Y-adjacent), not a bargain | The clean read now spans six full cycles |
| Heaviest captured selling, mostly against intact structure | LLY (-$3.0B), PLTR (-$2.4B), AVGO (-$1.6B), PANW (-$1.4B), SNOW (-$1.1B), NFLX (-$1.0B), NET (-$765.8M), DOCN (-$677.6M) | AMD/MRVL/DOCN sit against strongly positive multi-year trends; NFLX is the one name where selling and genuine chart damage (-35.69% 1Y, -10.3% vs 200-day) point the same direction |
| AVGO crossed below its 200-day this cycle, confirmed against the summary | -2.2% vs 200-day, -$1.6B tracked insider selling alongside the break | Full detail in the companion bargain-bin/tech-insider-buys scans |
| ASAN's earnings question fully resolved | overdue-unconfirmed → captured, confirmed Q2 beat; a sourced news pull (fetched 09-09) attributes the post-print drop specifically to guidance, not the print |
Clean illustration of separating a confirmed filed event from the news commentary explaining the tape reaction |
Pending Research Actions
| Action | Source | Priority | Status |
|---|---|---|---|
| Does the bond complex's slide into capitulation-adjacent territory (IEF/HYG/BND/LQD all 26-30) mark a floor, or is this the credit-stress episode the desk has watched build since HYG's death cross two cycles ago? | market-pulse, macro-commodities | High | 🆕 New, escalated |
| Does TJX's third-straight-scan capitulation (RSI 17.8, 1Y now negative) find a floor, or deepen further on nothing newer than a three-week-old downgrade? | retail-scan | High | Carried, escalated (3rd cycle) |
| Do SBUX and DPZ's unexplained sharp drops (both stale/failed news receipts checked) resolve, or extend? | consumer-scan, retail-scan, cultural-thesis, defensive-scan | High | 🆕 New |
| Does AMGN's 31-point RSI collapse (checked in three separate scans, no cause found in any) ever surface a sourced driver? | biotech-scan, healthcare-scan, tech-insider-buys | High | 🆕 New |
| Does CEG's reversal below its 200-day on a confirmed dilutive $3.09B raise stabilize, or deepen into a genuine trend break? | ai-scan, tech-insider-buys, energy candidate | High | 🆕 New |
Does defense ever catch a war premium, or does it keep trading purely as a rates proxy — LHX now in full collapse, RTX the lone name above its 200-day? |
defense-contractors, geopolitical-risk | High | Carried, escalated |
| Does the chemicals sector's broadening deterioration (PPG, SHW, APD, LIN all newly damaged) stabilize, or keep widening beyond Dow's original death cross? | chemicals | Medium | 🆕 New |
| Does RARE's deepening capitulation (-54.2% 1Y, no cause found across two straight scans) find a floor, or continue as a genuine multi-quarter breakdown? | biotech-scan | Medium | Carried, escalated |
| Is NET's sourced +9.9% pop (fresh OpenAI/SpaceX partnership news) a durable re-rate, or a one-cycle catalyst? | cybersec, ai-scan, web-cloud candidate | Medium | 🆕 New |
| Does Oracle reclaim and hold $167.64 (its 200-day) with free cash flow turning less negative, or does a second consecutive quarter of equity/debt raising confirm the financing gap is structural? | 2026-09-11-ORCL company profile | Medium | 🆕 New (from profile refresh) |
The Gold
Top Signal
The rates-not-fear read the desk has carried for two cycles just got its clearest confirmation yet: the bond complex crossed from oversold into outright capitulation-adjacent territory the same week oil kept extending and gold/silver took a direct, dated hit rather than a haven bid. IEF, HYG, BND and LQD all now sit at or below RSI 30, every one death-crossed and negative on both the trailing year and vs its 200-day — the sharpest single-corner deterioration on the whole board, worse than anything in equities. That happened during the exact dated session this desk's own September 10 brief documents (crude past $100, the ten-year above 4.9%, 844 of 1,115 broad-tape names lower), and defense — the sector a naive war narrative would expect to catch a bid — instead fell deeper into disrepair, with LHX now in a full
collapseregime and RTX the only prime left standing above its own 200-day. Against that backdrop, the broad equity benchmarks (SPY, QQQ, VTI) all cooled on RSI but held their 200-day cushions and double-digit trailing-year gains — a deep pullback across the market by the desk's own rule, not a breakdown, even as individual names in consumer (TJX, SBUX, DPZ), healthcare (AMGN, SYK, RARE) and chemicals (PPG, SHW, APD) crashed hard with no sourced cause behind most of the moves. The one place a genuinely durable trend just failed outright is credit — that is the thing to watch into next cycle, not any single equity name.
Key Discoveries
| Discovery | Implication |
|---|---|
| The bond complex (IEF, HYG, BND, LQD) fell from oversold into capitulation-adjacent territory (RSI 26-30), every name death-crossed and negative on 1Y and vs 200-day | Real, unambiguous credit deterioration underneath a still-orderly-looking equity tape |
| Gold and silver both widened their gap below the 200-day the same dated session oil pushed toward overbought (USO RSI 71.9, +112.19% 1Y) | Reinforces the rates/inflation read with a specific dated receipt, not just inference |
Defense fell deeper into disrepair (LHX now collapse) during a live, dated Middle East exchange |
Continues to confirm this is a rates story catching the sector hard, not a war-premium trade |
| TJX deepened into capitulation for a third straight scan and turned negative on the trailing year for the first time, on nothing newer than a three-week-old downgrade | The longest-running unresolved disconnect on the retail board |
| AMGN's 31-point RSI collapse has no established cause across three separate scan checks this session, while its long-trend numbers (+33.5% 1Y, +5.0% vs 200-day) stay intact | A genuinely sharp, unexplained pullback inside an otherwise healthy trend — worth a direct follow-up, not a dismissal |
| CEG crossed back below its 200-day on a confirmed, dated $3.09B dilutive equity raise, reversing a recovery tracked for two straight cycles | A real, sourced catalyst — not an unexplained technical break |
| Oracle drained its entire $20B at-the-market equity program in a single quarter and posted a fifth straight negative free-cash-flow quarter against a $664B contracted backlog | The AI-compute demand question reads as answered; the financing question is now the entire thesis on this name |
| The WFE/test-metrology equipment book (14 names) extended its clean bounce — every single name still carries a positive alpha1y, no exceptions | The cleanest "deep pullback in an intact trend" case on the entire board this cycle |
Sourced from all 31 of today's scans (monster-discover excluded, invalidated) + all 11 candidate roundups + the code-diffed regime-transitions feed (regimes:feed --json, 2026-09-11 snapshot vs 2026-09-10) + the 2026-09-11 ORCL company-profile refresh (signal only). Every price/RSI figure in this digest was validated directly against its source research/market-engine/data/summaries/*.json file this session. Prior digest for carry-forward: research/issues/2026-09-04-actions-daily-digest.md (7-day gap).
Sources
- Price/RSI/trend/long-horizon truth:
research/market-engine/data/summaries/*.json(2026-09-11 close), spot-checked directly this session for retail.json, biotech-scan.json, drone-defense.json, defense-contractors.json, bargain-bin.json, tech-insider-buys.json, cybersec.json, mag7.json, market-pulse.json, etf-ideas.json — and cross-read against chemicals.json, healthcare.json, travel-leisure.json, consumer.json, ev-clean-energy.json, ai-scan.json, insider-universe.json, supply-chain-traces.json, geopolitical.json, macro-commodities.json, optical-supply-chain.json, wfe-test-metrology.json, crypto.json, cloud-etfs.json, airlines.json, food-security.json, cultural-thesis.json, cybersec.json, defensive.json, washout-scan output, monster-scan output. - Scan corpus:
research/scans/2026-09-11-*.md(31 files: ai-infrastructure, ai-scan, airlines, bargain-bin, biotech-scan, chemicals, cloud-etfs, consumer-scan, crypto-scan, cultural-thesis, cybersec, defense-contractors, defensive-scan, drone-defense, etf-universe, ev-clean-energy, food-security, geopolitical-risk, healthcare-scan, insider-scan, macro-commodities, market-pulse, monster-discover [excluded], monster-scan, nvda-ecosystem, optical-supply-chain, retail-scan, supply-chain-traces, tech-insider-buys, travel-leisure, washout-scan, wfe-test-metrology). - Candidate roundups:
research/candidates/2026-09-11-*.md(11 files: ai-infra, biotech, cloud-saas, consumer, crypto, energy, mag7, memory, retail, space, web-cloud). - Regime transitions:
deno task market -- regimes:feed --json(2026-09-11 snapshot, diffed against 2026-09-10). - Company profile (signal only, not price-truth for entry zones):
research/company-profiles/2026-09-11-ORCL.md. - News/event receipts cited inline per scan: CEG equity raise (news fetched 2026-09-11), NET OpenAI/SpaceX partnerships (news fetched 2026-09-11), AVAV Q1 FY27 beat-and-raise (news fetched 2026-09-11, Benzinga), CIEN fiscal Q3 beat-and-raise (news fetched 2026-09-11, Ciena IR release), ASAN earnings resolution (
research/stock-events/2026-09-03-asan-earnings.md, news fetched 2026-09-09), ADBE Q3 beat (research/stock-events/2026-09-10-adbe-earnings.md), oil/rate macro captures (research/capture/articles/2026-09-09-bloomberg-*,2026-09-09-cnbc-*,2026-09-10-bloomberg-*). - Exit alerts: not populated this cycle — book-blind by explicit instruction; no holdings/ledger data was read.
- Prior digest for carry-forward:
research/issues/2026-09-04-actions-daily-digest.md.
No direct external sources are attached to this read.